`To:
`Subject:
`Date:
`
`ded_nefreply@ded.uscourts.gov
`ded_ecf@ded.uscourts.gov
`[EXT] Activity in Case . In Re: Ozempic (Semaglutide) Patent Litigation Stipulation
`Monday, February 26, 2024 3:41:44 PM
`
`This is an automatic e-mail message generated by the CM/ECF system. Please DO NOT
`RESPOND to this e-mail because the mail box is unattended.
`***NOTE TO PUBLIC ACCESS USERS*** Judicial Conference of the United States
`policy permits attorneys of record and parties in a case (including pro se litigants) to
`receive one free electronic copy of all documents filed electronically, if receipt is required
`by law or directed by the filer. PACER access fees apply to all other users. To avoid later
`charges, download a copy of each document during this first viewing. However, if the
`referenced document is a transcript, the free copy and 30 page limit do not apply.
`
`U.S. District Court
`
`District of Delaware
`
`Notice of Electronic Filing
`
`The following transaction was entered by Metzler, Sara on 2/26/2024 at 3:40 PM EST and
`filed on 2/26/2024
`Case Name:
`Case Number:
`Filer:
`
`Novo Nordisk Inc. et al v. Rio Biopharmaceuticals, Inc. et al
`1:22-cv-00294-CFC
`Sun Pharmaceutical Industries Ltd.
`Sun Pharmaceutical Industries Inc.
`Document Number: 275
`
`Docket Text:
`STIPULATION of Invalidity Contentions by Sun Pharmaceutical Industries Ltd.,
`Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..
`(Metzler, Sara)
`
`Case Name:
`Case Number:
`Filer:
`
`In Re: Ozempic (Semaglutide) Patent Litigation
`1:22-md-03038-CFC
`Sun Pharmaceutical Industries Ltd.
`Sun Pharmaceuticals Industries Inc.
`Document Number: 314
`
`Docket Text:
`STIPULATION of Invalidity Contentions by Sun Pharmaceutical Industries Ltd.,
`Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..
`(Metzler, Sara)
`
`1:22-cv-00294-CFC Notice has been electronically mailed to:
`
`Alexis Stombaugh astombaugh@ycst.com, corpcal@ycst.com, corporate@ycst.com
`
`Novo Nordisk Exhibit 2547
`Mylan Pharms. Inc. v. Novo Nordisk A/S
`IPR2023-00724
`Page 00001
`
`
`
`Alison M. King AMKing@winston.com
`
`Ashley Graham agraham@winston.com
`
`Brian P. Egan began@mnat.com, bpeefiling@mnat.com,
`mnat_IP_eFiling@morrisnichols.com
`
`Carolyn A. Blessing cblessing@lockelord.com, ewilson@lockelord.com
`
`Christopher B. Ferenc christopher.ferenc@katten.com, dawn.el-khoury@katten.com
`
`Christopher W. West christopher.west@katten.com
`
`David B. Abramowitz dabramowitz@lockelord.com, kim.ingle@lockelord.com
`
`Dominick T. Gattuso dgattuso@hegh.law, RMarshall@hegh.law
`
`Hannah M. Shankman hshankman@winston.com
`
`Jack B. Blumenfeld Jbbefiling@mnat.com, jblumenfeld@mnat.com,
`mnat_IP_eFiling@morrisnichols.com
`
`Jacob C. Britz jacob.britz@lockelord.com, AutoDocket@lockelord.com
`
`Jaimin H. Shah jshah@taftlaw.com, pskinner@taftlaw.com
`
`Jovial Wong jwong@winston.com
`
`Kelly E. Farnan farnan@rlf.com, linda-loveless-5548@ecf.pacerpro.com, loveless@rlf.com
`
`Kenneth Laurence Dorsney kdorsney@morrisjames.com, CHitch@morrisjames.com,
`ippara@morrisjames.com
`
`Michael J. Gaertner mgaertner@lockelord.com, mklimasara@lockelord.com
`
`Philip Y. Kouyoumdjian pkouyoumdjian@taftlaw.com, schang@taftlaw.com
`
`Pilar Gabrielle Kraman pkraman@ycst.com, corpcal@ycst.com, corporate@ycst.com
`
`Sharon Lin slin@winston.com
`
`Stephen R. Auten sauten@taftlaw.com, bkann@taftlaw.com
`
`Travis J Murray tmurray@morrisnichols.com
`
`1:22-cv-00294-CFC Filer will deliver document by other means to:
`
`1:22-md-03038-CFC Notice has been electronically mailed to:
`
`Alexis Stombaugh astombaugh@ycst.com, corpcal@ycst.com, corporate@ycst.com
`
`Novo Nordisk Exhibit 2547
`Mylan Pharms. Inc. v. Novo Nordisk A/S
`IPR2023-00724
`Page 00002
`
`
`
`Alison M. King AMKing@winston.com
`
`Brandon M. White BMWhite@perkinscoie.com, docketwdc@perkinscoie.com
`
`Brian P. Egan began@mnat.com, bpeefiling@mnat.com,
`mnat_IP_eFiling@morrisnichols.com
`
`Bryan D. Beel bbeel@perkinscoie.com, khuang@perkinscoie.com
`
`Carolyn A. Blessing cblessing@lockelord.com, ewilson@lockelord.com
`
`Christopher B. Ferenc christopher.ferenc@katten.com, dawn.el-khoury@katten.com
`
`Christopher W. West christopher.west@katten.com
`
`David B. Abramowitz dabramowitz@lockelord.com, kim.ingle@lockelord.com
`
`Dominick T. Gattuso dgattuso@hegh.law, RMarshall@hegh.law
`
`Emily J. Greb egreb@perkinscoie.com, docketmadison@perkinscoie.com
`
`Gordon H. Copland Gordon.Copland@steptoe-johnson.com
`
`Hannah M. Shankman hshankman@winston.com
`
`Jack B. Blumenfeld Jbbefiling@mnat.com, jblumenfeld@mnat.com,
`mnat_IP_eFiling@morrisnichols.com
`
`Jacob C. Britz jacob.britz@lockelord.com, AutoDocket@lockelord.com
`
`Jovial Wong jwong@winston.com
`
`Kelly E. Farnan farnan@rlf.com, linda-loveless-5548@ecf.pacerpro.com, loveless@rlf.com
`
`Kenneth Laurence Dorsney kdorsney@morrisjames.com, CHitch@morrisjames.com,
`ippara@morrisjames.com
`
`Maria A. Stubbings MStubbings@perkinscoie.com
`
`Michael J. Gaertner mgaertner@lockelord.com, mklimasara@lockelord.com
`
`Pilar Gabrielle Kraman pkraman@ycst.com, corpcal@ycst.com, corporate@ycst.com
`
`Richard Charles Weinblatt weinblatt@swdelaw.com, filings@swdelaw.com
`
`Shannon M. Bloodworth SBloodworth@perkinscoie.com, DocketWDC@perkinscoie.com
`
`Sharon Lin slin@winston.com
`
`Stamatios Stamoulis stamoulis@swdelaw.com, bill.rodgers@viatris.com,
`
`Novo Nordisk Exhibit 2547
`Mylan Pharms. Inc. v. Novo Nordisk A/S
`IPR2023-00724
`Page 00003
`
`
`
`filings@swdelaw.com, jill.ondos@viatris.com, matthew.greinert@viatris.com,
`preston.imperatore@viatris.com, Tom.Jenkins@viatris.com
`
`Travis J Murray tmurray@morrisnichols.com
`
`William J O'Brien William.Obrien@Steptoe-Johnson.com
`
`1:22-md-03038-CFC Filer will deliver document by other means to:
`
`The following document(s) are associated with this transaction:
`
`Document description:Main Document
`Original filename:n/a
`Electronic document Stamp:
`[STAMP dcecfStamp_ID=1079733196 [Date=2/26/2024] [FileNumber=5475773-0
`] [b414005bd342ee39699965a7989e1f22b5d3d00f2c795e0c9d6d89d2f0f28da6ebb
`6fd12c60af2b4609772e9348c08f6cbb5b8f322d833101bb62ebea34743bf]]
`
`Novo Nordisk Exhibit 2547
`Mylan Pharms. Inc. v. Novo Nordisk A/S
`IPR2023-00724
`Page 00004
`
`